Abstracts

Search by keyword or author name.

Showing 852 abstracts.

Sharon Appelbaum Nachman, M.D., Lin-Ye Song, Ph.D., Mark J. Abzug, M.D. Safety and Immunogenicity of pneumococcal conjugate vaccine (PCV) and routine pediatric immunizations in HIV infected on HAART (PACTG 1024). Presented at: 43rd Intersci Conf on Antimicrobial Agents & Chemotherapy.

Conference

43rd Intersci Conf on Antimicrobial Agents & Chemotherapy

Study

P1024
John S. Lambert, M.D. Safety and Immunogenicity of Recombinant Envelope HIV Vaccines in Asymptomatic HIV Infected Children.
Coleen Cunningham, Ulla Buchholz, Petronella Muresan, Elizabeth McFarland, Cindy Luongo, Peter Collins, Bhavin Thumar, Betty Schappell, Devasena Gnanashanmugam, George Siberry, Vivian Rexroad, Ruth Karron. Safety and Immunogenicity of the Recombinant Live-Attenuated Respiratory syncytial Virus Vaccine RSV cps2 in RSV-seronegative Infants and Children. Presented at: IDWeek 2015.

Conference

IDWeek 2015

Study

P1114
Coleen Cunningham, Ulla Buchholz, Petronella Muresan, Elizabeth McFarland, Cindy Luongo, Peter Collins, Bhavin Thumar, Betty Schappell, Devasena Gnanashanmugam, George Siberry, Vivian Rexroad, Ruth Karron. Safety and immunogenicity of the recombinant live-attenuated respiratory syncytial virus vaccine RSV cps2 in RSV-seronegative infants and children. Presented at: ID Week 2015.

Conference

ID Week 2015
Safety and Immunogenicity of Two Doses of Monovalent Pandemic H1N1 (pH1N1) Influenza Vaccine in HIV-Infected Pregnant Women. Presented at: 48th Annual Meeting of Infectious Diseases Society of Amercia.

Conference

48th Annual Meeting of Infectious Diseases Society of Amercia

Study

P1086
John S. Lambert, M.D. Safety and Pharmacokinetics of Hyperimmune HIV Immunoglobulin (HIVIG) in HIV+ Pregnant Women and Newborns.
Moherndran Archary, Jorge Pinto, Edmund Capparelli, Edward P. Acosta, S. Y. Amy Cheung, Thomas N. Kakuda, Ellen M. Townley, Jack Moye, Ryan Milligan, Rachel Scheckter, Gaerolwe Masheto, Pradthana Ounchanum, Linda Aurpibul, Lee Fairlie , CRAYON Study Team. Safety and pharmacokinetics of long-acting cabotegravir and rilpivirine in children between 20-40 kg.
Mo Archary, Jorge Pinto, Edmund Caparelli, Ed Acosta, Amy Cheung, Herta Crauwels, Ellen Townley, Jack Moye, Mark Giganti, Rachel Scheckter, Barb Heckman, Cristina Hofer, Mrinmayee Dhar, Sisinyana Ruth Mathiba, CRAYON/IMPAACT 2036 Study Team. Safety and pharmacokinetics of long-acting cabotegravir and rilpivirine in young children 10 to 40 kg. Presented at: CROI 2026; 2026 Feb 24.

Conference

CROI 2026

Study

IMPAACT 2036
EJ MacFarland, CK Cunningham, EV Capparelli, P Muresan, E Smith, C Perlowski, L Morrison, P Morgan, AB McDermott, R Hazra, JR Mascola, B Graham. Safety and pharmacokinetics of monoclonal antibody VRC01LS in HIV-exposed newborns. Presented at: CROI 2019; 2019 Mar 05.

Conference

CROI 2019

Study

P1112
Peggy Weintrub, M.D. Safety and Pharmacokinetics of Recombinant CD4 in Children with HIV Infection.